Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of MHC class I biosynthetic process (GO:0045343) | 9.94821170 |
2 | negative regulation of type 2 immune response (GO:0002829) | 9.91166069 |
3 | sex differentiation (GO:0007548) | 8.92607828 |
4 | stress granule assembly (GO:0034063) | 7.89851849 |
5 | regulation of interleukin-13 production (GO:0032656) | 7.87713626 |
6 | cholesterol catabolic process (GO:0006707) | 7.54027803 |
7 | sterol catabolic process (GO:0016127) | 7.54027803 |
8 | cerebellar Purkinje cell differentiation (GO:0021702) | 6.97375387 |
9 | alternative mRNA splicing, via spliceosome (GO:0000380) | 6.93754264 |
10 | positive regulation of vasculogenesis (GO:2001214) | 6.74263514 |
11 | regulation of interleukin-5 production (GO:0032674) | 6.62872720 |
12 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 6.36605094 |
13 | ADP metabolic process (GO:0046031) | 6.10899958 |
14 | kynurenine metabolic process (GO:0070189) | 6.03038119 |
15 | nucleoside diphosphate catabolic process (GO:0009134) | 5.96613875 |
16 | regulation of metalloenzyme activity (GO:0048552) | 5.74978051 |
17 | indole-containing compound catabolic process (GO:0042436) | 5.49164878 |
18 | indolalkylamine catabolic process (GO:0046218) | 5.49164878 |
19 | tryptophan catabolic process (GO:0006569) | 5.49164878 |
20 | regulation of vasculogenesis (GO:2001212) | 5.47034592 |
21 | centrosome duplication (GO:0051298) | 5.46441828 |
22 | lipid particle organization (GO:0034389) | 5.35038329 |
23 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 5.08863255 |
24 | bile acid biosynthetic process (GO:0006699) | 4.68082478 |
25 | tryptophan metabolic process (GO:0006568) | 4.61241028 |
26 | regulation of action potential (GO:0098900) | 4.53372864 |
27 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.30241544 |
28 | acrosome assembly (GO:0001675) | 4.20666389 |
29 | chondrocyte proliferation (GO:0035988) | 4.18152277 |
30 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.10427861 |
31 | negative regulation of endothelial cell proliferation (GO:0001937) | 4.09436988 |
32 | negative regulation of mast cell activation (GO:0033004) | 4.02975693 |
33 | positive regulation of heat generation (GO:0031652) | 3.95967664 |
34 | somite rostral/caudal axis specification (GO:0032525) | 3.95256611 |
35 | response to X-ray (GO:0010165) | 3.85488310 |
36 | protein autoprocessing (GO:0016540) | 3.83760569 |
37 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.79942845 |
38 | negative regulation of T cell differentiation (GO:0045581) | 3.77415565 |
39 | synaptic transmission, cholinergic (GO:0007271) | 3.72763982 |
40 | ganglion development (GO:0061548) | 3.69376852 |
41 | phospholipid translocation (GO:0045332) | 3.69332045 |
42 | lipid translocation (GO:0034204) | 3.69332045 |
43 | regulation of triglyceride catabolic process (GO:0010896) | 3.69113377 |
44 | estrogen biosynthetic process (GO:0006703) | 3.66033124 |
45 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.60978137 |
46 | regulation of sequestering of triglyceride (GO:0010889) | 3.60715229 |
47 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.60332802 |
48 | neuronal action potential propagation (GO:0019227) | 3.59198615 |
49 | histone H3-K4 trimethylation (GO:0080182) | 3.56075181 |
50 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.53593586 |
51 | regulation of type 2 immune response (GO:0002828) | 3.51229329 |
52 | central nervous system neuron axonogenesis (GO:0021955) | 3.49997820 |
53 | indolalkylamine metabolic process (GO:0006586) | 3.49172993 |
54 | regulation of heat generation (GO:0031650) | 3.46069952 |
55 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.45632213 |
56 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.45632213 |
57 | steroid catabolic process (GO:0006706) | 3.41464233 |
58 | regulation of receptor internalization (GO:0002090) | 3.37806276 |
59 | cell differentiation in hindbrain (GO:0021533) | 3.37142535 |
60 | cell adhesion mediated by integrin (GO:0033627) | 3.36158688 |
61 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.34549033 |
62 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.34549033 |
63 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.34549033 |
64 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.34283664 |
65 | negative regulation of organ growth (GO:0046621) | 3.31906729 |
66 | response to lipoprotein particle (GO:0055094) | 3.29926033 |
67 | L-fucose metabolic process (GO:0042354) | 3.29874032 |
68 | L-fucose catabolic process (GO:0042355) | 3.29874032 |
69 | fucose catabolic process (GO:0019317) | 3.29874032 |
70 | seminiferous tubule development (GO:0072520) | 3.27804764 |
71 | regulation of establishment of cell polarity (GO:2000114) | 3.24084296 |
72 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.23810341 |
73 | regulation of superoxide metabolic process (GO:0090322) | 3.23387580 |
74 | cellular biogenic amine catabolic process (GO:0042402) | 3.23341450 |
75 | amine catabolic process (GO:0009310) | 3.23341450 |
76 | positive regulation of fatty acid oxidation (GO:0046321) | 3.22921330 |
77 | NAD biosynthetic process (GO:0009435) | 3.22389891 |
78 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.21084639 |
79 | neural tube formation (GO:0001841) | 3.20285830 |
80 | fibroblast migration (GO:0010761) | 3.19265032 |
81 | negative regulation of endothelial cell migration (GO:0010596) | 3.17151808 |
82 | collagen fibril organization (GO:0030199) | 3.16820414 |
83 | regulation of RNA export from nucleus (GO:0046831) | 3.15191108 |
84 | aromatic amino acid family catabolic process (GO:0009074) | 3.14987868 |
85 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.07683152 |
86 | histone H3-K9 demethylation (GO:0033169) | 3.06828646 |
87 | lactate metabolic process (GO:0006089) | 3.06125601 |
88 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.99703972 |
89 | face morphogenesis (GO:0060325) | 2.97627342 |
90 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.95536212 |
91 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.95536212 |
92 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.95536212 |
93 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.95078346 |
94 | nuclear pore complex assembly (GO:0051292) | 2.92852094 |
95 | histone demethylation (GO:0016577) | 2.91786883 |
96 | histone lysine demethylation (GO:0070076) | 2.91456120 |
97 | L-methionine salvage (GO:0071267) | 2.89917499 |
98 | L-methionine biosynthetic process (GO:0071265) | 2.89917499 |
99 | amino acid salvage (GO:0043102) | 2.89917499 |
100 | craniofacial suture morphogenesis (GO:0097094) | 2.87928954 |
101 | cranial suture morphogenesis (GO:0060363) | 2.87717200 |
102 | termination of RNA polymerase III transcription (GO:0006386) | 2.86911288 |
103 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.86911288 |
104 | skin morphogenesis (GO:0043589) | 2.83008625 |
105 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.82565161 |
106 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.82314770 |
107 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.81873570 |
108 | regulation of response to reactive oxygen species (GO:1901031) | 2.81180781 |
109 | radial glial cell differentiation (GO:0060019) | 2.80218048 |
110 | mesodermal cell differentiation (GO:0048333) | 2.78938951 |
111 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.78738650 |
112 | one-carbon compound transport (GO:0019755) | 2.78667817 |
113 | wound healing, spreading of epidermal cells (GO:0035313) | 2.77407512 |
114 | hippo signaling (GO:0035329) | 2.77377766 |
115 | regulation of gene silencing by RNA (GO:0060966) | 2.76575855 |
116 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.76575855 |
117 | regulation of gene silencing by miRNA (GO:0060964) | 2.76575855 |
118 | cellular ketone body metabolic process (GO:0046950) | 2.76406303 |
119 | negative regulation of fatty acid transport (GO:2000192) | 2.75546175 |
120 | smooth muscle tissue development (GO:0048745) | 2.74655759 |
121 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.72164147 |
122 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.69549081 |
123 | mitotic sister chromatid cohesion (GO:0007064) | 2.69372315 |
124 | protein heterotrimerization (GO:0070208) | 2.68810226 |
125 | ovulation from ovarian follicle (GO:0001542) | 2.68786467 |
126 | auditory receptor cell stereocilium organization (GO:0060088) | 2.68743858 |
127 | pigmentation (GO:0043473) | 2.67937396 |
128 | histone H3-K36 demethylation (GO:0070544) | 2.67401308 |
129 | adult walking behavior (GO:0007628) | 2.67000537 |
130 | myoblast migration (GO:0051451) | 2.65181803 |
131 | metallo-sulfur cluster assembly (GO:0031163) | 2.64669819 |
132 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.63466098 |
133 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.60391568 |
134 | protein demethylation (GO:0006482) | 2.55444199 |
135 | protein dealkylation (GO:0008214) | 2.55444199 |
136 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.54473788 |
137 | regulation of protein polyubiquitination (GO:1902914) | 2.53057369 |
138 | cartilage morphogenesis (GO:0060536) | 2.49792444 |
139 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.48484513 |
140 | regulation of tight junction assembly (GO:2000810) | 2.47375508 |
141 | pore complex assembly (GO:0046931) | 2.45959237 |
142 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.45485765 |
143 | maturation of 5.8S rRNA (GO:0000460) | 2.44631795 |
144 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.44500173 |
145 | germ cell migration (GO:0008354) | 2.43936053 |
146 | embryonic process involved in female pregnancy (GO:0060136) | 2.43434034 |
147 | axon extension involved in axon guidance (GO:0048846) | 2.42038455 |
148 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.42038455 |
149 | cellular response to gamma radiation (GO:0071480) | 2.41484570 |
150 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.39663364 |
151 | cellular response to arsenic-containing substance (GO:0071243) | 2.38097997 |
152 | protein localization to cell surface (GO:0034394) | 2.37324657 |
153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.36929927 |
154 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.36929927 |
155 | protein localization to endosome (GO:0036010) | 2.36837685 |
156 | regulation of germinal center formation (GO:0002634) | 2.36287318 |
157 | morphogenesis of an epithelial sheet (GO:0002011) | 2.35987853 |
158 | endodermal cell differentiation (GO:0035987) | 2.35718748 |
159 | growth hormone receptor signaling pathway (GO:0060396) | 2.34273423 |
160 | nuclear pore organization (GO:0006999) | 2.33637966 |
161 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 2.31731017 |
162 | Notch signaling involved in heart development (GO:0061314) | 2.31269765 |
163 | positive regulation of p38MAPK cascade (GO:1900745) | 2.29038692 |
164 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.28885247 |
165 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.27812202 |
166 | wound healing, spreading of cells (GO:0044319) | 2.26901990 |
167 | positive regulation of cartilage development (GO:0061036) | 2.24523865 |
168 | notochord development (GO:0030903) | 2.24383607 |
169 | definitive hemopoiesis (GO:0060216) | 2.22293571 |
170 | chondrocyte development (GO:0002063) | 2.21481629 |
171 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.21064491 |
172 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 2.17676134 |
173 | hepatocyte apoptotic process (GO:0097284) | 2.17154342 |
174 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.15751548 |
175 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.15751548 |
176 | neural crest cell development (GO:0014032) | 2.15530084 |
177 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.14157450 |
178 | lymph vessel development (GO:0001945) | 2.12075317 |
179 | positive regulation of stem cell differentiation (GO:2000738) | 2.11117773 |
180 | mRNA transcription (GO:0009299) | 2.10945866 |
181 | megakaryocyte development (GO:0035855) | 2.10838994 |
182 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.10609198 |
183 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 2.10539740 |
184 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.10061986 |
185 | SMAD protein complex assembly (GO:0007183) | 2.10052965 |
186 | regulation of keratinocyte differentiation (GO:0045616) | 2.09967655 |
187 | response to arsenic-containing substance (GO:0046685) | 2.09843207 |
188 | phagocytosis, engulfment (GO:0006911) | 2.09753142 |
189 | corticosteroid receptor signaling pathway (GO:0031958) | 2.09690157 |
190 | protein localization to kinetochore (GO:0034501) | 2.06832059 |
191 | response to fluid shear stress (GO:0034405) | 2.06653910 |
192 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.04850738 |
193 | pericardium development (GO:0060039) | 2.03315777 |
194 | positive regulation of mRNA catabolic process (GO:0061014) | 2.02962535 |
195 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.01647925 |
196 | regulation of memory T cell differentiation (GO:0043380) | 12.2121993 |
197 | negative regulation of multicellular organism growth (GO:0040015) | 11.2327424 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VDR_22108803_ChIP-Seq_LS180_Human | 4.48530244 |
2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.55799173 |
3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.10194360 |
4 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.09109053 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.99062491 |
6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.91865123 |
7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.83707037 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76494770 |
9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.73518116 |
10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.62727273 |
11 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.54995599 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45457381 |
13 | TP53_16413492_ChIP-PET_HCT116_Human | 2.28621581 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.28486159 |
15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.24508128 |
16 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.22973784 |
17 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.17914555 |
18 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.14591240 |
19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06571170 |
20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.06560830 |
21 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.06517123 |
22 | * BCAT_22108803_ChIP-Seq_LS180_Human | 2.05809836 |
23 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.03437347 |
24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.91834464 |
25 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.86527006 |
26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.82483838 |
27 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.80836090 |
28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74522261 |
29 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.73402577 |
30 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.73402577 |
31 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73374310 |
32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.71533364 |
33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.68190262 |
34 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.67307980 |
35 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.62089990 |
36 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.60586996 |
37 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.60257447 |
38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.58681368 |
39 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.56240634 |
40 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52789804 |
41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52692001 |
42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52111915 |
43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51590706 |
44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51493414 |
45 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.51227303 |
46 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.50669599 |
47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49372158 |
48 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.48672957 |
49 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46521979 |
50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45449997 |
51 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44183594 |
52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43505308 |
53 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.42875957 |
54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.42683581 |
55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42049658 |
56 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.39988792 |
57 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.39978762 |
58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.38097282 |
59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37252218 |
60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35046280 |
61 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34362001 |
62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33941130 |
63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33941130 |
64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29754904 |
65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29754904 |
66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29743143 |
67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29445717 |
68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28765755 |
69 | TBL1_22424771_ChIP-Seq_293T_Human | 1.28131128 |
70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27801870 |
71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27438317 |
72 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.26738832 |
73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25984988 |
74 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.25681642 |
75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24231011 |
76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23119440 |
77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22431876 |
78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21409560 |
79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18929922 |
80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17344123 |
81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17156056 |
82 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16300622 |
83 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.15837846 |
84 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.15393801 |
85 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15213595 |
86 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15014206 |
87 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14692206 |
88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14172515 |
89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13948170 |
90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13716735 |
91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13585016 |
92 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.13478079 |
93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13467734 |
94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13467734 |
95 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.12777570 |
96 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12698646 |
97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12520161 |
98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12418363 |
99 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12369049 |
100 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12310043 |
101 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12171816 |
102 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12002972 |
103 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11774828 |
104 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11756355 |
105 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.11057487 |
106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10459053 |
107 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10393372 |
108 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10183967 |
109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10150378 |
110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10117742 |
111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09223643 |
112 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09070954 |
113 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07286489 |
114 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07084036 |
115 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06642427 |
116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06250017 |
117 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06030970 |
118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05952722 |
119 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05743749 |
120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04668767 |
121 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04495105 |
122 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04415218 |
123 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04198369 |
124 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.03442961 |
125 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03066915 |
126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02683441 |
127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02572157 |
128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02475880 |
129 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01647660 |
130 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.01596486 |
131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01381894 |
132 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01095677 |
133 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00791330 |
134 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.99117873 |
135 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99070145 |
136 | NCOR_22424771_ChIP-Seq_293T_Human | 0.98990803 |
137 | NFYA_21822215_ChIP-Seq_K562_Human | 0.98901143 |
138 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98699496 |
139 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98573651 |
140 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98377256 |
141 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97661835 |
142 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97429962 |
143 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97048717 |
144 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96622228 |
145 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96559307 |
146 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96428242 |
147 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96275205 |
148 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96201146 |
149 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96074366 |
150 | NFYB_21822215_ChIP-Seq_K562_Human | 0.95919406 |
151 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95126588 |
152 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94700742 |
153 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.94099078 |
154 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93732079 |
155 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93400946 |
156 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.93288575 |
157 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92967916 |
158 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92949772 |
159 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91759211 |
160 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91221598 |
161 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89076706 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003252_abnormal_bile_duct | 7.02512904 |
2 | MP0003011_delayed_dark_adaptation | 5.96285499 |
3 | MP0002736_abnormal_nociception_after | 4.65683110 |
4 | MP0008438_abnormal_cutaneous_collagen | 3.96143149 |
5 | MP0001968_abnormal_touch/_nociception | 3.62138797 |
6 | MP0001986_abnormal_taste_sensitivity | 3.59213744 |
7 | MP0002877_abnormal_melanocyte_morpholog | 3.10607638 |
8 | MP0000371_diluted_coat_color | 3.02823588 |
9 | MP0005275_abnormal_skin_tensile | 2.99307446 |
10 | MP0005503_abnormal_tendon_morphology | 2.74626852 |
11 | MP0010352_gastrointestinal_tract_polyps | 2.59695319 |
12 | MP0003195_calcinosis | 2.49580800 |
13 | MP0005253_abnormal_eye_physiology | 2.38876228 |
14 | MP0001501_abnormal_sleep_pattern | 2.37096569 |
15 | MP0003279_aneurysm | 2.32509768 |
16 | MP0003091_abnormal_cell_migration | 2.27458047 |
17 | MP0005623_abnormal_meninges_morphology | 2.24047564 |
18 | MP0005646_abnormal_pituitary_gland | 2.24038809 |
19 | MP0009745_abnormal_behavioral_response | 2.23632594 |
20 | MP0005076_abnormal_cell_differentiation | 2.22911618 |
21 | MP0000733_abnormal_muscle_development | 2.16432101 |
22 | MP0002837_dystrophic_cardiac_calcinosis | 2.14144687 |
23 | MP0002102_abnormal_ear_morphology | 2.12803307 |
24 | MP0003705_abnormal_hypodermis_morpholog | 2.12475814 |
25 | MP0002060_abnormal_skin_morphology | 2.09653949 |
26 | MP0010368_abnormal_lymphatic_system | 2.01900077 |
27 | MP0002009_preneoplasia | 1.99741454 |
28 | MP0009384_cardiac_valve_regurgitation | 1.96459431 |
29 | MP0006072_abnormal_retinal_apoptosis | 1.95709108 |
30 | MP0000516_abnormal_urinary_system | 1.88127833 |
31 | MP0005367_renal/urinary_system_phenotyp | 1.88127833 |
32 | MP0000569_abnormal_digit_pigmentation | 1.87466279 |
33 | MP0005508_abnormal_skeleton_morphology | 1.84241455 |
34 | MP0003941_abnormal_skin_development | 1.82551753 |
35 | MP0000767_abnormal_smooth_muscle | 1.73680507 |
36 | MP0005647_abnormal_sex_gland | 1.68658106 |
37 | MP0010234_abnormal_vibrissa_follicle | 1.67646956 |
38 | MP0009250_abnormal_appendicular_skeleto | 1.66249553 |
39 | MP0010307_abnormal_tumor_latency | 1.65693667 |
40 | MP0005551_abnormal_eye_electrophysiolog | 1.64276054 |
41 | MP0008007_abnormal_cellular_replicative | 1.63534299 |
42 | MP0005171_absent_coat_pigmentation | 1.62627606 |
43 | MP0001299_abnormal_eye_distance/ | 1.60738320 |
44 | MP0002282_abnormal_trachea_morphology | 1.58048135 |
45 | MP0003718_maternal_effect | 1.55995112 |
46 | MP0003755_abnormal_palate_morphology | 1.53696712 |
47 | MP0009046_muscle_twitch | 1.53273795 |
48 | MP0001958_emphysema | 1.52167556 |
49 | MP0003137_abnormal_impulse_conducting | 1.50424044 |
50 | MP0003950_abnormal_plasma_membrane | 1.46508699 |
51 | MP0003300_gastrointestinal_ulcer | 1.46090011 |
52 | MP0003828_pulmonary_edema | 1.45226997 |
53 | MP0002234_abnormal_pharynx_morphology | 1.44913287 |
54 | MP0004808_abnormal_hematopoietic_stem | 1.44737594 |
55 | MP0004885_abnormal_endolymph | 1.44676323 |
56 | MP0010386_abnormal_urinary_bladder | 1.43776322 |
57 | MP0004272_abnormal_basement_membrane | 1.43592337 |
58 | MP0003385_abnormal_body_wall | 1.41522495 |
59 | MP0002166_altered_tumor_susceptibility | 1.40795477 |
60 | MP0005174_abnormal_tail_pigmentation | 1.39385181 |
61 | MP0005257_abnormal_intraocular_pressure | 1.37871436 |
62 | MP0005334_abnormal_fat_pad | 1.37346907 |
63 | MP0003787_abnormal_imprinting | 1.34928574 |
64 | MP0001486_abnormal_startle_reflex | 1.33819078 |
65 | MP0003186_abnormal_redox_activity | 1.32552120 |
66 | MP0010678_abnormal_skin_adnexa | 1.32284737 |
67 | MP0003566_abnormal_cell_adhesion | 1.32117107 |
68 | MP0002108_abnormal_muscle_morphology | 1.30895104 |
69 | MP0005023_abnormal_wound_healing | 1.30604937 |
70 | MP0000432_abnormal_head_morphology | 1.30338279 |
71 | MP0006054_spinal_hemorrhage | 1.27820067 |
72 | MP0001177_atelectasis | 1.27111854 |
73 | MP0003172_abnormal_lysosome_physiology | 1.23373874 |
74 | MP0004130_abnormal_muscle_cell | 1.23357873 |
75 | MP0005083_abnormal_biliary_tract | 1.21967569 |
76 | MP0006035_abnormal_mitochondrial_morpho | 1.20905098 |
77 | MP0001915_intracranial_hemorrhage | 1.20639982 |
78 | MP0000427_abnormal_hair_cycle | 1.19942029 |
79 | MP0001851_eye_inflammation | 1.18852817 |
80 | MP0003453_abnormal_keratinocyte_physiol | 1.18072263 |
81 | MP0003119_abnormal_digestive_system | 1.18041669 |
82 | MP0002177_abnormal_outer_ear | 1.17691786 |
83 | MP0003937_abnormal_limbs/digits/tail_de | 1.17192262 |
84 | MP0002638_abnormal_pupillary_reflex | 1.16766102 |
85 | MP0002272_abnormal_nervous_system | 1.16599218 |
86 | MP0003646_muscle_fatigue | 1.16549000 |
87 | MP0002006_tumorigenesis | 1.16447355 |
88 | MP0009053_abnormal_anal_canal | 1.15279310 |
89 | MP0001666_abnormal_nutrient_absorption | 1.14637727 |
90 | MP0001879_abnormal_lymphatic_vessel | 1.14417645 |
91 | MP0002075_abnormal_coat/hair_pigmentati | 1.13709447 |
92 | MP0003935_abnormal_craniofacial_develop | 1.13555780 |
93 | MP0002138_abnormal_hepatobiliary_system | 1.13045011 |
94 | MP0002064_seizures | 1.12800701 |
95 | MP0004264_abnormal_extraembryonic_tissu | 1.09496993 |
96 | MP0005075_abnormal_melanosome_morpholog | 1.09103659 |
97 | MP0004924_abnormal_behavior | 1.06878674 |
98 | MP0005386_behavior/neurological_phenoty | 1.06878674 |
99 | MP0005197_abnormal_uvea_morphology | 1.05658514 |
100 | MP0004381_abnormal_hair_follicle | 1.05572157 |
101 | MP0008877_abnormal_DNA_methylation | 1.05437519 |
102 | MP0000428_abnormal_craniofacial_morphol | 1.05133513 |
103 | MP0005390_skeleton_phenotype | 1.05127591 |
104 | MP0002113_abnormal_skeleton_development | 1.04569120 |
105 | MP0001243_abnormal_dermal_layer | 1.04283292 |
106 | MP0004510_myositis | 1.03531211 |
107 | MP0010030_abnormal_orbit_morphology | 1.03242742 |
108 | MP0004043_abnormal_pH_regulation | 1.01884033 |
109 | MP0000566_synostosis | 0.99958213 |
110 | MP0000383_abnormal_hair_follicle | 0.99874418 |
111 | MP0000749_muscle_degeneration | 0.99488471 |
112 | MP0003115_abnormal_respiratory_system | 0.98938037 |
113 | MP0005248_abnormal_Harderian_gland | 0.98601532 |
114 | MP0002925_abnormal_cardiovascular_devel | 0.98564075 |
115 | MP0002233_abnormal_nose_morphology | 0.98483555 |
116 | MP0003045_fibrosis | 0.97040990 |
117 | MP0005410_abnormal_fertilization | 0.96007244 |
118 | MP0002396_abnormal_hematopoietic_system | 0.94341915 |
119 | MP0002116_abnormal_craniofacial_bone | 0.94337917 |
120 | MP0005388_respiratory_system_phenotype | 0.94310357 |
121 | MP0002133_abnormal_respiratory_system | 0.94310357 |
122 | MP0002693_abnormal_pancreas_physiology | 0.93959252 |
123 | MP0001340_abnormal_eyelid_morphology | 0.93635536 |
124 | MP0002932_abnormal_joint_morphology | 0.93234000 |
125 | MP0002998_abnormal_bone_remodeling | 0.93052979 |
126 | MP0002115_abnormal_skeleton_extremities | 0.90832126 |
127 | MP0008961_abnormal_basal_metabolism | 0.89289851 |
128 | MP0002109_abnormal_limb_morphology | 0.88275641 |
129 | MP0001346_abnormal_lacrimal_gland | 0.88025520 |
130 | MP0003938_abnormal_ear_development | 0.87771714 |
131 | MP0002254_reproductive_system_inflammat | 0.87281959 |
132 | MP0002128_abnormal_blood_circulation | 0.87139577 |
133 | MP0009840_abnormal_foam_cell | 0.86737186 |
134 | MP0000163_abnormal_cartilage_morphology | 0.86696327 |
135 | MP0001348_abnormal_lacrimal_gland | 0.86475102 |
136 | MP0003943_abnormal_hepatobiliary_system | 0.86335409 |
137 | MP0003936_abnormal_reproductive_system | 0.86306341 |
138 | MP0008057_abnormal_DNA_replication | 0.84821806 |
139 | MP0004147_increased_porphyrin_level | 0.84752968 |
140 | MP0001542_abnormal_bone_strength | 0.84437492 |
141 | MP0002896_abnormal_bone_mineralization | 0.84069482 |
142 | MP0003890_abnormal_embryonic-extraembry | 0.84045632 |
143 | MP0003448_altered_tumor_morphology | 0.83982719 |
144 | MP0001944_abnormal_pancreas_morphology | 0.83473750 |
145 | MP0000627_abnormal_mammary_gland | 0.83222162 |
146 | MP0004197_abnormal_fetal_growth/weight/ | 0.83011450 |
147 | MP0001191_abnormal_skin_condition | 0.82694262 |
148 | MP0002697_abnormal_eye_size | 0.81192327 |
149 | MP0001324_abnormal_eye_pigmentation | 0.80892291 |
150 | MP0002928_abnormal_bile_duct | 0.79615363 |
151 | MP0001614_abnormal_blood_vessel | 0.79281320 |
152 | MP0004134_abnormal_chest_morphology | 0.78410005 |
153 | MP0001216_abnormal_epidermal_layer | 0.78206618 |
154 | MP0005395_other_phenotype | 0.77362958 |
155 | MP0002733_abnormal_thermal_nociception | 0.77329206 |
156 | MP0001784_abnormal_fluid_regulation | 0.76856806 |
157 | MP0000653_abnormal_sex_gland | 0.76744012 |
158 | MP0005391_vision/eye_phenotype | 0.76638113 |
159 | MP0000647_abnormal_sebaceous_gland | 0.75887263 |
160 | MP0006138_congestive_heart_failure | 0.75639619 |
161 | MP0001286_abnormal_eye_development | 0.75067367 |
162 | MP0002118_abnormal_lipid_homeostasis | 0.74552373 |
163 | MP0005636_abnormal_mineral_homeostasis | 0.71645281 |
164 | MP0005310_abnormal_salivary_gland | 0.71289239 |
165 | MP0002751_abnormal_autonomic_nervous | 0.70102744 |
166 | MP0001186_pigmentation_phenotype | 0.69441234 |
167 | MP0005084_abnormal_gallbladder_morpholo | 0.68399348 |
168 | MP0000631_abnormal_neuroendocrine_gland | 0.65705368 |
169 | MP0005620_abnormal_muscle_contractility | 0.65119357 |
170 | MP0002163_abnormal_gland_morphology | 0.64978252 |
171 | MP0002067_abnormal_sensory_capabilities | 0.64545635 |
172 | MP0002938_white_spotting | 0.63313756 |
173 | MP0004742_abnormal_vestibular_system | 0.61052735 |
174 | MP0002876_abnormal_thyroid_physiology | 0.60329086 |
175 | MP0005330_cardiomyopathy | 0.59964631 |
176 | MP0001764_abnormal_homeostasis | 0.59620647 |
177 | MP0008770_decreased_survivor_rate | 0.57474424 |
178 | MP0001119_abnormal_female_reproductive | 0.56939734 |
179 | MP0000026_abnormal_inner_ear | 0.55904975 |
180 | MP0000470_abnormal_stomach_morphology | 0.55300073 |
181 | MP0000372_irregular_coat_pigmentation | 0.54912455 |
182 | MP0002084_abnormal_developmental_patter | 0.54226678 |
183 | MP0005408_hypopigmentation | 0.52940614 |
184 | MP0009697_abnormal_copulation | 0.52628880 |
185 | MP0006036_abnormal_mitochondrial_physio | 0.52309993 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Progressive cerebellar ataxia (HP:0002073) | 8.48730839 |
2 | Gaze-evoked nystagmus (HP:0000640) | 5.92065553 |
3 | Absence seizures (HP:0002121) | 5.89163575 |
4 | Pendular nystagmus (HP:0012043) | 5.75997409 |
5 | Abnormality of the hepatic vasculature (HP:0006707) | 5.56448660 |
6 | Urinary bladder sphincter dysfunction (HP:0002839) | 5.43030499 |
7 | Slow saccadic eye movements (HP:0000514) | 5.39866201 |
8 | Postural tremor (HP:0002174) | 5.07736529 |
9 | Dysdiadochokinesis (HP:0002075) | 4.94329760 |
10 | Premature rupture of membranes (HP:0001788) | 4.87343557 |
11 | Postural instability (HP:0002172) | 4.77619312 |
12 | Dialeptic seizures (HP:0011146) | 4.62150261 |
13 | Impaired vibratory sensation (HP:0002495) | 4.46979558 |
14 | Focal seizures (HP:0007359) | 4.33447175 |
15 | Severe visual impairment (HP:0001141) | 4.29077287 |
16 | Asymmetry of the thorax (HP:0001555) | 4.28199441 |
17 | Hypochromic microcytic anemia (HP:0004840) | 4.23043724 |
18 | Syringomyelia (HP:0003396) | 4.22511907 |
19 | Spinal cord lesions (HP:0100561) | 4.22511907 |
20 | Limb ataxia (HP:0002070) | 4.12320855 |
21 | Impaired smooth pursuit (HP:0007772) | 3.90431368 |
22 | Protrusio acetabuli (HP:0003179) | 3.90081550 |
23 | Abnormality of the prostate (HP:0008775) | 3.79442711 |
24 | Shallow orbits (HP:0000586) | 3.69406596 |
25 | Impaired proprioception (HP:0010831) | 3.48905175 |
26 | Abnormality of macular pigmentation (HP:0008002) | 3.36419008 |
27 | Hyperventilation (HP:0002883) | 3.17515571 |
28 | Atrophic scars (HP:0001075) | 3.04438135 |
29 | Focal motor seizures (HP:0011153) | 2.94771127 |
30 | Aortic dissection (HP:0002647) | 2.93173474 |
31 | Postnatal microcephaly (HP:0005484) | 2.90064760 |
32 | Chorioretinal atrophy (HP:0000533) | 2.85633758 |
33 | Keratoconus (HP:0000563) | 2.82774356 |
34 | Increased corneal curvature (HP:0100692) | 2.82774356 |
35 | Areflexia of lower limbs (HP:0002522) | 2.82517868 |
36 | Atonic seizures (HP:0010819) | 2.78057873 |
37 | Abnormality of the nasal septum (HP:0000419) | 2.77410453 |
38 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.69087210 |
39 | Vitreoretinal degeneration (HP:0000655) | 2.68150960 |
40 | Rib fusion (HP:0000902) | 2.65783966 |
41 | Hematochezia (HP:0002573) | 2.63915705 |
42 | Genu recurvatum (HP:0002816) | 2.59942924 |
43 | Soft skin (HP:0000977) | 2.58681459 |
44 | Cervical subluxation (HP:0003308) | 2.57832939 |
45 | Bilateral microphthalmos (HP:0007633) | 2.53450119 |
46 | Febrile seizures (HP:0002373) | 2.53091435 |
47 | Distal lower limb amyotrophy (HP:0008944) | 2.52491117 |
48 | Fragile skin (HP:0001030) | 2.49509448 |
49 | Follicular hyperkeratosis (HP:0007502) | 2.47710361 |
50 | Peritonitis (HP:0002586) | 2.47601238 |
51 | Osteolytic defects of the hand bones (HP:0009699) | 2.46210004 |
52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.46210004 |
53 | Mitral valve prolapse (HP:0001634) | 2.42812877 |
54 | Abnormality of vision evoked potentials (HP:0000649) | 2.42733827 |
55 | Aortic aneurysm (HP:0004942) | 2.40029660 |
56 | Neoplasm of the adrenal cortex (HP:0100641) | 2.39307811 |
57 | Fair hair (HP:0002286) | 2.38391713 |
58 | Severe Myopia (HP:0011003) | 2.36082505 |
59 | Urethral obstruction (HP:0000796) | 2.33127313 |
60 | Biliary tract neoplasm (HP:0100574) | 2.31522831 |
61 | Short nail (HP:0001799) | 2.31250614 |
62 | Enlarged penis (HP:0000040) | 2.28079313 |
63 | Oculomotor apraxia (HP:0000657) | 2.23899969 |
64 | Wormian bones (HP:0002645) | 2.23453965 |
65 | Hypochromic anemia (HP:0001931) | 2.23390860 |
66 | Cerebral aneurysm (HP:0004944) | 2.22987755 |
67 | Abnormality of male internal genitalia (HP:0000022) | 2.22875489 |
68 | Vascular tortuosity (HP:0004948) | 2.21142189 |
69 | Absent frontal sinuses (HP:0002688) | 2.20736236 |
70 | Abnormality of saccadic eye movements (HP:0000570) | 2.19629534 |
71 | Mesomelia (HP:0003027) | 2.17375971 |
72 | Ankle contracture (HP:0006466) | 2.17161407 |
73 | Dilatation of the ascending aorta (HP:0005111) | 2.16310776 |
74 | Lower limb amyotrophy (HP:0007210) | 2.16201827 |
75 | Clumsiness (HP:0002312) | 2.14776601 |
76 | Proximal tubulopathy (HP:0000114) | 2.14615845 |
77 | Retinitis pigmentosa (HP:0000510) | 2.13488906 |
78 | Persistence of primary teeth (HP:0006335) | 2.11092741 |
79 | Pancreatic cysts (HP:0001737) | 2.11002867 |
80 | Increased connective tissue (HP:0009025) | 2.09884401 |
81 | Acute myeloid leukemia (HP:0004808) | 2.09316333 |
82 | Alopecia of scalp (HP:0002293) | 2.07381155 |
83 | Decreased muscle mass (HP:0003199) | 2.05805691 |
84 | Short 4th metacarpal (HP:0010044) | 2.05790209 |
85 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.05790209 |
86 | Sparse lateral eyebrow (HP:0005338) | 2.01578874 |
87 | Dislocated radial head (HP:0003083) | 2.01434548 |
88 | Genetic anticipation (HP:0003743) | 11.4696725 |
89 | Action tremor (HP:0002345) | 10.1016951 |
90 | Dysmetric saccades (HP:0000641) | 10.0616333 |
91 | Hemiparesis (HP:0001269) | 1.99578929 |
92 | Wrist flexion contracture (HP:0001239) | 1.98685962 |
93 | Broad ribs (HP:0000885) | 1.97764403 |
94 | Arterial tortuosity (HP:0005116) | 1.97428588 |
95 | Prostate neoplasm (HP:0100787) | 1.97251753 |
96 | Spinal rigidity (HP:0003306) | 1.95953220 |
97 | Thick nail (HP:0001805) | 1.94428284 |
98 | Overgrowth (HP:0001548) | 1.94191663 |
99 | Bladder diverticulum (HP:0000015) | 1.94182926 |
100 | Increased density of long bones (HP:0006392) | 1.93312965 |
101 | Exostoses (HP:0100777) | 1.92360420 |
102 | Neonatal short-limb short stature (HP:0008921) | 1.92278316 |
103 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.91320304 |
104 | Hypoplasia of the fovea (HP:0007750) | 1.91320304 |
105 | Anomalous pulmonary venous return (HP:0010772) | 1.90537450 |
106 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.90249697 |
107 | Hypoplasia of the maxilla (HP:0000327) | 1.90230893 |
108 | Abnormality of the frontal sinuses (HP:0002687) | 1.89917574 |
109 | Portal hypertension (HP:0001409) | 1.89519772 |
110 | Bradykinesia (HP:0002067) | 1.88938039 |
111 | Lip pit (HP:0100267) | 1.88851432 |
112 | Macroorchidism (HP:0000053) | 1.88726337 |
113 | Abnormality of the radial head (HP:0003995) | 1.87333882 |
114 | Protruding tongue (HP:0010808) | 1.87220307 |
115 | Abnormal delivery (HP:0001787) | 1.87192775 |
116 | Long eyelashes (HP:0000527) | 1.86914816 |
117 | Cutaneous melanoma (HP:0012056) | 1.86104411 |
118 | Spondylolisthesis (HP:0003302) | 1.85336523 |
119 | Elbow flexion contracture (HP:0002987) | 1.84562392 |
120 | Abnormality of the fingertips (HP:0001211) | 1.82959043 |
121 | Narrow palate (HP:0000189) | 1.82901786 |
122 | True hermaphroditism (HP:0010459) | 1.82100120 |
123 | Broad metatarsal (HP:0001783) | 1.82077139 |
124 | Capillary hemangiomas (HP:0005306) | 1.81818295 |
125 | Hypoplastic ischia (HP:0003175) | 1.80729324 |
126 | Microglossia (HP:0000171) | 1.80691821 |
127 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80148843 |
128 | Generalized hypopigmentation of hair (HP:0011358) | 1.78706642 |
129 | Deviation of the hallux (HP:0010051) | 1.78635432 |
130 | Pancreatic fibrosis (HP:0100732) | 1.78339416 |
131 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.75549302 |
132 | Tinnitus (HP:0000360) | 1.75064070 |
133 | Abnormality of the neuromuscular junction (HP:0003398) | 1.74706260 |
134 | Fatigable weakness (HP:0003473) | 1.74706260 |
135 | Hypophosphatemic rickets (HP:0004912) | 1.73781758 |
136 | Myocardial infarction (HP:0001658) | 1.73515814 |
137 | Bell-shaped thorax (HP:0001591) | 1.73311956 |
138 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.73241963 |
139 | Camptodactyly of toe (HP:0001836) | 1.72655842 |
140 | Type 1 muscle fiber predominance (HP:0003803) | 1.72582000 |
141 | Hypoproteinemia (HP:0003075) | 1.72179939 |
142 | Hallux valgus (HP:0001822) | 1.72069852 |
143 | Decreased central vision (HP:0007663) | 1.71547840 |
144 | Congenital stationary night blindness (HP:0007642) | 1.71434090 |
145 | Absent speech (HP:0001344) | 1.71246457 |
146 | Joint laxity (HP:0001388) | 1.71234942 |
147 | Aqueductal stenosis (HP:0002410) | 1.69876899 |
148 | Abnormality of the pulmonary veins (HP:0011718) | 1.69757917 |
149 | Bowel diverticulosis (HP:0005222) | 1.69025217 |
150 | Abolished electroretinogram (ERG) (HP:0000550) | 1.68859431 |
151 | Cystic hygroma (HP:0000476) | 1.68678204 |
152 | Blue sclerae (HP:0000592) | 1.68279239 |
153 | Abnormality of the humeroradial joint (HP:0100744) | 1.67648348 |
154 | Tubular atrophy (HP:0000092) | 1.67111669 |
155 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.66770028 |
156 | Abnormal biliary tract morphology (HP:0012440) | 1.66457501 |
157 | Buphthalmos (HP:0000557) | 1.66111766 |
158 | Abnormality of the ischium (HP:0003174) | 1.65960397 |
159 | Hip contracture (HP:0003273) | 1.64419203 |
160 | Natal tooth (HP:0000695) | 1.63810031 |
161 | Abnormality of dentin (HP:0010299) | 1.63796387 |
162 | Macular degeneration (HP:0000608) | 1.62475297 |
163 | Knee flexion contracture (HP:0006380) | 1.62054193 |
164 | Deep philtrum (HP:0002002) | 1.61704827 |
165 | Subacute progressive viral hepatitis (HP:0006572) | 1.60928087 |
166 | Papillary thyroid carcinoma (HP:0002895) | 1.59603311 |
167 | Volvulus (HP:0002580) | 1.59547041 |
168 | Hyperthyroidism (HP:0000836) | 1.59354178 |
169 | Hypoplastic iliac wings (HP:0002866) | 1.57744455 |
170 | Craniofacial hyperostosis (HP:0004493) | 1.57146257 |
171 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.56878878 |
172 | Fibular aplasia (HP:0002990) | 1.56717973 |
173 | Advanced eruption of teeth (HP:0006288) | 1.54467371 |
174 | Disproportionate short-trunk short stature (HP:0003521) | 1.54461764 |
175 | Muscle fiber splitting (HP:0003555) | 1.54129140 |
176 | Chromsome breakage (HP:0040012) | 1.53839280 |
177 | Increased number of teeth (HP:0011069) | 1.53450456 |
178 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.53278275 |
179 | Horizontal nystagmus (HP:0000666) | 1.52854221 |
180 | Incomplete penetrance (HP:0003829) | 1.52806378 |
181 | Thyroid carcinoma (HP:0002890) | 1.52698442 |
182 | Dysmetria (HP:0001310) | 1.51008705 |
183 | Nephronophthisis (HP:0000090) | 1.50085057 |
184 | Broad-based gait (HP:0002136) | 1.50042794 |
185 | Macroglossia (HP:0000158) | 1.49294094 |
186 | Gingival bleeding (HP:0000225) | 1.49159021 |
187 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.47383850 |
188 | Absent/shortened dynein arms (HP:0200106) | 1.47383850 |
189 | Abnormality of the fovea (HP:0000493) | 1.46203588 |
190 | Fasciculations (HP:0002380) | 1.46165529 |
191 | Hemiplegia (HP:0002301) | 1.45862211 |
192 | Blue irides (HP:0000635) | 1.43514958 |
193 | Loss of speech (HP:0002371) | 1.43303974 |
194 | Attenuation of retinal blood vessels (HP:0007843) | 1.42699959 |
195 | Inability to walk (HP:0002540) | 1.40593068 |
196 | Concave nail (HP:0001598) | 1.40534266 |
197 | Exotropia (HP:0000577) | 1.39283126 |
198 | Scrotal hypoplasia (HP:0000046) | 1.39149397 |
199 | Hypobetalipoproteinemia (HP:0003563) | 1.38583572 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OXSR1 | 6.18099238 |
2 | FRK | 3.82075110 |
3 | MKNK1 | 3.34523605 |
4 | MKNK2 | 3.31566301 |
5 | LATS1 | 3.08090014 |
6 | MUSK | 3.03339674 |
7 | ERBB3 | 2.72416604 |
8 | GRK1 | 2.63160695 |
9 | MAP3K7 | 2.39633049 |
10 | LATS2 | 2.21474517 |
11 | ACVR1B | 2.19354969 |
12 | TNK2 | 2.11817564 |
13 | FGFR3 | 2.08575681 |
14 | FGFR2 | 2.08223185 |
15 | TRPM7 | 2.02805525 |
16 | MAP3K14 | 2.02260385 |
17 | CDK19 | 10.4201465 |
18 | BCR | 1.80292354 |
19 | STK3 | 1.80024361 |
20 | CDK12 | 1.74827925 |
21 | DDR2 | 1.72160839 |
22 | CHUK | 1.68175329 |
23 | BRD4 | 1.66911953 |
24 | EPHB1 | 1.66688195 |
25 | EPHA3 | 1.66266971 |
26 | ERBB4 | 1.62244563 |
27 | PDGFRA | 1.55829882 |
28 | PINK1 | 1.55322075 |
29 | DMPK | 1.55253220 |
30 | TGFBR2 | 1.50088175 |
31 | TXK | 1.40150629 |
32 | ADRBK2 | 1.35307370 |
33 | ZAK | 1.31758593 |
34 | NLK | 1.30905128 |
35 | STK38L | 1.30741708 |
36 | SGK2 | 1.30640361 |
37 | RPS6KA4 | 1.30416741 |
38 | TTN | 1.29374312 |
39 | BRSK2 | 1.24513304 |
40 | BMPR2 | 1.14449577 |
41 | CDK9 | 1.14212169 |
42 | PDGFRB | 1.13972211 |
43 | RIPK1 | 1.13491206 |
44 | CDK3 | 1.10379801 |
45 | SGK3 | 1.10298537 |
46 | ALK | 1.09282348 |
47 | RPS6KB2 | 1.08800027 |
48 | NEK9 | 1.07840895 |
49 | IKBKB | 1.05201787 |
50 | BMX | 1.04727151 |
51 | NUAK1 | 1.01143569 |
52 | STK10 | 1.00193122 |
53 | PAK2 | 0.99845857 |
54 | CDK8 | 0.98190831 |
55 | TGFBR1 | 0.96382190 |
56 | PIM1 | 0.96369098 |
57 | MELK | 0.94354564 |
58 | STK38 | 0.92672861 |
59 | EIF2AK2 | 0.91693721 |
60 | MARK3 | 0.91073549 |
61 | PTK2 | 0.89903795 |
62 | CASK | 0.89587298 |
63 | MAP3K6 | 0.88192847 |
64 | CDK6 | 0.87672506 |
65 | WNK3 | 0.84679504 |
66 | DYRK1B | 0.84665982 |
67 | PTK6 | 0.83835957 |
68 | PRKAA2 | 0.81497449 |
69 | MAPKAPK5 | 0.79740158 |
70 | JAK1 | 0.79708771 |
71 | JAK3 | 0.77542411 |
72 | EPHA2 | 0.77250139 |
73 | TAOK3 | 0.76934057 |
74 | MOS | 0.75158679 |
75 | RPS6KA5 | 0.74582820 |
76 | PLK3 | 0.73972226 |
77 | TAF1 | 0.73465463 |
78 | MAP3K3 | 0.72740121 |
79 | CAMK1D | 0.71071433 |
80 | IRAK3 | 0.70926961 |
81 | GSK3A | 0.67951873 |
82 | WEE1 | 0.66884726 |
83 | PAK3 | 0.66591251 |
84 | MTOR | 0.65580478 |
85 | PIK3CA | 0.60417054 |
86 | WNK4 | 0.60390941 |
87 | MAP3K5 | 0.58940515 |
88 | ABL1 | 0.58419353 |
89 | SGK223 | 0.57956252 |
90 | SGK494 | 0.57956252 |
91 | CAMK1G | 0.57671211 |
92 | CLK1 | 0.55262897 |
93 | NEK6 | 0.54418942 |
94 | MAPK7 | 0.54228586 |
95 | TIE1 | 0.54169479 |
96 | DYRK1A | 0.53865149 |
97 | TNIK | 0.52889783 |
98 | PRPF4B | 0.52832967 |
99 | INSRR | 0.52367279 |
100 | MAPK13 | 0.50919330 |
101 | ADRBK1 | 0.50315557 |
102 | IKBKE | 0.50155572 |
103 | SIK1 | 0.49811287 |
104 | PLK2 | 0.49377648 |
105 | FER | 0.49370587 |
106 | EPHB2 | 0.49054020 |
107 | STK24 | 0.48317632 |
108 | CSNK1G2 | 0.47713448 |
109 | STK4 | 0.47103362 |
110 | MAPKAPK2 | 0.47040596 |
111 | MST4 | 0.46298012 |
112 | FGFR1 | 0.46010687 |
113 | PIM2 | 0.44909621 |
114 | DYRK3 | 0.44617794 |
115 | AKT3 | 0.44525768 |
116 | PTK2B | 0.44090022 |
117 | SGK1 | 0.43547961 |
118 | MAP2K1 | 0.43199569 |
119 | CSNK1A1L | 0.42528745 |
120 | TRIM28 | 0.42448193 |
121 | MAPK8 | 0.41018089 |
122 | CSNK1G1 | 0.40865137 |
123 | BMPR1B | 0.40236091 |
124 | MAPK1 | 0.39687905 |
125 | MAP3K4 | 0.39512582 |
126 | MAP4K2 | 0.39165003 |
127 | HIPK2 | 0.38329968 |
128 | STK39 | 0.38250059 |
129 | DYRK2 | 0.38032906 |
130 | STK11 | 0.37955454 |
131 | PKN1 | 0.37674986 |
132 | CSNK1G3 | 0.36715171 |
133 | MAPK15 | 0.36415241 |
134 | FGFR4 | 0.36334773 |
135 | CHEK2 | 0.36236376 |
136 | CHEK1 | 0.33520195 |
137 | ERBB2 | 0.30905427 |
138 | PRKCG | 0.29883350 |
139 | JAK2 | 0.29849434 |
140 | PRKCE | 0.29698413 |
141 | PDK1 | 0.29692682 |
142 | PRKG1 | 0.28120546 |
143 | CDK5 | 0.25037328 |
144 | PDPK1 | 0.24829381 |
145 | PRKAA1 | 0.24230689 |
146 | OBSCN | 0.22100785 |
147 | MARK1 | 0.22000617 |
148 | GRK5 | 0.21473345 |
149 | CSNK1A1 | 0.20656075 |
150 | CDK18 | 0.20221998 |
151 | CAMK2A | 0.19613940 |
152 | DAPK2 | 0.19459494 |
153 | EIF2AK3 | 0.18762454 |
154 | RPS6KB1 | 0.17932850 |
155 | CDK15 | 0.17460508 |
156 | CSNK1D | 0.16990600 |
157 | AKT1 | 0.13447189 |
158 | VRK2 | 0.12513040 |
159 | NTRK3 | 0.10454809 |
160 | CDK11A | 0.08180054 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 8.32379746 |
2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.94083824 |
3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.50654000 |
4 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.47948764 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22436369 |
6 | RNA polymerase_Homo sapiens_hsa03020 | 2.19496678 |
7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.12570206 |
8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.02807703 |
9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01697762 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99578354 |
11 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.99454765 |
12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.99448431 |
13 | Retinol metabolism_Homo sapiens_hsa00830 | 1.97216980 |
14 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92571013 |
15 | Adherens junction_Homo sapiens_hsa04520 | 1.92238608 |
16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.92044097 |
17 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.90261775 |
18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87865879 |
19 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.85952004 |
20 | Focal adhesion_Homo sapiens_hsa04510 | 1.80468675 |
21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.79183898 |
22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.76983616 |
23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76835593 |
24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.73550732 |
25 | Prostate cancer_Homo sapiens_hsa05215 | 1.66167584 |
26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62696899 |
27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56805863 |
28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.50293524 |
29 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.50219380 |
30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45881752 |
31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40043052 |
32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37569656 |
33 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.37528832 |
34 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.35955132 |
35 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.34453957 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33107602 |
37 | Hepatitis B_Homo sapiens_hsa05161 | 1.30792876 |
38 | Malaria_Homo sapiens_hsa05144 | 1.26687594 |
39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.26570435 |
40 | Melanoma_Homo sapiens_hsa05218 | 1.25811962 |
41 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.25152555 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24752453 |
43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24363937 |
44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20244864 |
45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.19843433 |
46 | Phototransduction_Homo sapiens_hsa04744 | 1.16945474 |
47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16616916 |
48 | HTLV-I infection_Homo sapiens_hsa05166 | 1.15873004 |
49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.15242089 |
50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14494301 |
51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.13375685 |
52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12103788 |
53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11384727 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10507206 |
55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.10201848 |
56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09143015 |
57 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.09102370 |
58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08822798 |
59 | Amoebiasis_Homo sapiens_hsa05146 | 1.08587231 |
60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07771522 |
61 | Taste transduction_Homo sapiens_hsa04742 | 1.07588958 |
62 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06754503 |
63 | Endometrial cancer_Homo sapiens_hsa05213 | 1.06403045 |
64 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05570116 |
65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05364370 |
66 | Pathways in cancer_Homo sapiens_hsa05200 | 1.03978103 |
67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02815658 |
68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.00968647 |
69 | Platelet activation_Homo sapiens_hsa04611 | 1.00787156 |
70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00517092 |
71 | Glioma_Homo sapiens_hsa05214 | 1.00370098 |
72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00082792 |
73 | Cell cycle_Homo sapiens_hsa04110 | 1.00000630 |
74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99508616 |
75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97751604 |
76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95510352 |
77 | Apoptosis_Homo sapiens_hsa04210 | 0.93659087 |
78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.93060286 |
79 | Salivary secretion_Homo sapiens_hsa04970 | 0.92957499 |
80 | Measles_Homo sapiens_hsa05162 | 0.90597460 |
81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89804596 |
82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89342121 |
83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88941592 |
84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88702902 |
85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88693747 |
86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88491286 |
87 | Bladder cancer_Homo sapiens_hsa05219 | 0.88227992 |
88 | Shigellosis_Homo sapiens_hsa05131 | 0.87981747 |
89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86629113 |
90 | Tight junction_Homo sapiens_hsa04530 | 0.85828677 |
91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.85599882 |
92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85480702 |
93 | Axon guidance_Homo sapiens_hsa04360 | 0.85011547 |
94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84644948 |
95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84593936 |
96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84414070 |
97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83014512 |
98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82756386 |
99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82747769 |
100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82465819 |
101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81452926 |
102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.80452126 |
103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80299439 |
104 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79557414 |
105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79463207 |
106 | ABC transporters_Homo sapiens_hsa02010 | 0.79406877 |
107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78761030 |
108 | Morphine addiction_Homo sapiens_hsa05032 | 0.77285215 |
109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76449052 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.75968092 |
111 | Purine metabolism_Homo sapiens_hsa00230 | 0.75957770 |
112 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75707506 |
113 | Nicotine addiction_Homo sapiens_hsa05033 | 0.75637096 |
114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75475972 |
115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74835939 |
116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.74505400 |
117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74342921 |
118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72035071 |
119 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71633765 |
120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71054239 |
121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69502677 |
122 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69242908 |
123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68505356 |
124 | Salmonella infection_Homo sapiens_hsa05132 | 0.68437728 |
125 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67843158 |
126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66220544 |
127 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65657533 |
128 | Influenza A_Homo sapiens_hsa05164 | 0.63312257 |
129 | Long-term depression_Homo sapiens_hsa04730 | 0.63218699 |
130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62767886 |
131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62660395 |
132 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62175393 |
133 | Hepatitis C_Homo sapiens_hsa05160 | 0.61956292 |
134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61395796 |
135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61060465 |
136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60783155 |
137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60021933 |
138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59959388 |
139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59385931 |
140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59167235 |
141 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57599783 |
142 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57057426 |
143 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56765824 |
144 | Lysine degradation_Homo sapiens_hsa00310 | 0.55030559 |
145 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54629236 |
146 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54375355 |
147 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54063509 |
148 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53862398 |
149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53756390 |
150 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53446963 |
151 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52937029 |
152 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.52668911 |
153 | Homologous recombination_Homo sapiens_hsa03440 | 0.50404753 |
154 | Insulin secretion_Homo sapiens_hsa04911 | 0.45595018 |
155 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44850169 |
156 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43917611 |
157 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42893918 |
158 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42863983 |
159 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42699121 |
160 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42498196 |
161 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42170127 |
162 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41006174 |
163 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39223420 |
164 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38687801 |
165 | Renin secretion_Homo sapiens_hsa04924 | 0.38667605 |
166 | GABAergic synapse_Homo sapiens_hsa04727 | 0.37049822 |
167 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35860802 |
168 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35578658 |
169 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35203085 |
170 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34936562 |
171 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33088542 |
172 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.32144282 |
173 | Mineral absorption_Homo sapiens_hsa04978 | 0.31845279 |
174 | Peroxisome_Homo sapiens_hsa04146 | 0.29814753 |
175 | Cocaine addiction_Homo sapiens_hsa05030 | 0.27134029 |
176 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26597173 |
177 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25437002 |